Harvard Breast Cancer – New Horizons – Current Controversies 2023 (CME VIDEOS)

Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence and clinical skills of health care professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses and other clinicians involved in the care of breast cancer patients.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Apply knowledge of recent clinical data together with current expert recommendations to patient selection for new and emerging therapies for advanced breast cancer.
• Apply knowledge in the treatment of breast cancer in special populations (including the elderly and young women) and adjust treatment decisions for specific patients as needed.
• Select appropriate risk assessment modalities, where applicable and make evidence-based therapeutic selections for women who are candidates for neoadjuvant or adjuvant therapy and know the limitations of genomic testing.
• Apply recent clinical data and expert recommendations to the management of women with breast cancer who are treated with mastectomy, including integration of surgical methods, breast reconstruction options and post-mastectomy radiation if needed.
• Assess current practices with regard to symptom management during active treatment and in survivorship and consider the needs for fertility and lifestyle counseling among patients with breast cancer and survivors, and improve current practices if needed.
• Evaluate the genetic and personal risk factors of breast cancer and utilize appropriate genetic testing for hereditary breast cancer.

Agenda